Flag of the European Union EU Clinical Trials Register Help

Clinical trials for C8

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44343   clinical trials with a EudraCT protocol, of which   7372   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Aasenden R, Peebles TC. Effects of fluoride supplementation from birth on human deciduous and permanent teeth. Arch Oral Biol 1974; 19: 321-326.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24626
    Study title: Ala-Houhala M, Koskinen T, Koskinen M, Visakorpi JK.Double blind study on the need for vitamin D supplementation in prepubertal children.Acta Paediatr Scand. 1988 Jan;77(1):89-93.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24634
    Study title: Andersson R, Grahnen H. Fluoride tablets in pre-school age – effect on primary and permanet teeth. Swed Dent J 1976; 69: 137-143.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24627
    Study title: De Liefde B, Herbison GP. Prevalence of developmental defects of enamel and denatl caries in New Zealand children receiving differing fluoride supplementation. Community Dent Oral Epidemiol 1985; 13: 164-167
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24628
    Study title: Empfehlung der Deutschen Akademie fuer Kinderheilkunde und Jugendmedizin yur Kariesprophylaxe mit Fluoriden (Monatsschrift Kinderheilkunde 2000 148, 1154-57)
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24624
    Study title: Fábián K, Velkey L, Fodor E. [Preventive value of vitamin D in various doses based on a prospective study of healthy infants. [Article in Hungarian] Orv Hetil. 1990 Mar 4;131(9):447-50.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24635
    Study title: Fanning EA, Cellier KM, Leadbeater MM, Somerville CM. South Australian kindergarten children: fluoride tablet supplements and dental caries. Aust Dent J 1975: 20: 7-9
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24629
    Study title: Friis-Hasché E, Bergamnn J, Wenzel A, Thylstrup A et al. Dental health status and attitudes to dental care in families participating in a Danish fluoride tablet program. Community Dent Oral Epidemiol 1984; 12: 303-307
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24631
    Study title: Effect of caries-prophylaxis with Fluor-Vigantoletten 1000 on fluoride concentration in plasma of infants - Einfluß der Kariesprophylaxe mit Fluor-Vigantoletten 1000 auf die Plasma-Fluoridkonzentrationen beim Säugling.Monatsschr Kinderheilk 1979; 127: 192-195. Fuchs C.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results): 20140709_Art 45 Studies.xlsx
    View full study record
    Document reference: 24623
    Study title: Lehtonen-Veroma M, Mottonen T, Nuotio I et al. Vitamin D and attainment of peak bone mass among peripubertal Finish girls: a 3-year prospective study. Am J Clin Nutr 2002; 76: 1446-53.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24636
    Study title: Leverett DH, Adair SM, Vaughan BW et al. Randomized clinical trail of the effect of prenatal fluoride supplements in preventing dental caries. Caries res 1997; 31: 174-179.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24632
    Study title: Margolis FJ, Rheames HR, Freshman E et al. Fluoride: ten year prospective study of deciduous teeth and permanent dentition. Am J Dis Child 1975; 129: 794-800.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24633
    Study title: Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res. 2004 Aug;19(8):1221-30.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24637
    Study title: Nicolaidou P, Georgouli H, Kotsalis H, Matsinos Y, Papadopoulou A, Fretzayas A, Syriopoulou V, Krikos X, Karantana A, Karpathios T. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol. 2006 Mar;21(3):205-9.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24638
    Study title: Specker BL, Ho ML, Oestreich A, Yin TA, Shui QM, Chen XC, Tsang RC.Prospective study of vitamin D supplementation and rickets in China.J Pediatr. 1992 May;120(5):733-9.
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24639
    Study title: A Multiclinic Evaluation of the efficacy and safety of Ciprofloxacin Ophthalmic Ointment versus TOBREX Ophthalmic Ointment in treating bacterial conjuncivitis (C8824a).
    Active substance: TOBRAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 44815
    Study title: C8559 - November 15, 1989; C8569 (011:37150:0688) - June 30, 1988; C8569 (016:38610:0490) - March 14, 1994; C8569 (010:34350:1287) - April 21, 1988; C8569 (015:38610:0490) - November 5, 1990; C8569 (017:38610:0490) - June 16, 1994; C8569 (02:38610:0194) - July 6, 1994; C8569 (009:34350:1287) - April 21, 1988; C8569 (008:34350:1287) - April 21, 1988; C8569A (055:38610:1189) - November 13, 1989; C8569A (022:38610:0490) - November 6, 1990; C8569A (024:38610:0490) - May 27, 1994; C8881 - June 2, 1994; C9126 - April 21, 1995; C9144 - June 30, 1993; C9151 - August 3, 1994; C9165 - March 8, 1994; C9171 - June 29, 1993; C9274 - October 3, 1995
    Active substance: LODOXAMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 46926
    Study title: Efficacy and safety evaluation of Lodoxamide Ophthalmic Solution versus OPTICROM Ophthalmic Solution in patients with vernal conjunctivitis, giant papillary conjunctivitis and allergic/atopic conjunctivitis (C8559)
    Active substance: LODOXAMIDE
    Study summary document link (including results):
    View full study record
    Document reference: 46925
    Study title: Epidemiologische Begleituntersuchungen yur Gruppenprophylaxe 2000 - Gutachten (Prof. Dr. K. Pieper, im Auftrag der Deutschen Arbeitsgemeinschaft fuer Jugendzahnpflege, 2001 ISBN 3/926 228 16-4)
    Active substance: COLECALCIFEROL AND SODIUM FLUORIDE
    Study summary document link (including results):
    View full study record
    Document reference: 24625
    Study title: ND: 27179 AU: BOUISSOU F, FABRE C, REMESY M, MESTERY D,YUNG M, CABAL G, PIQUEMAL J, MARMIN G, BOESEN G, FOURES M F, BARTHE PH. IN: NEPHROLOGIE PEDIATRIQUE, HOPITAL DES ENFANTS, TOULOUSE, FRANCE. TI: CARNITINE SUPPLEMENTATION IN HEMODIALYSED CHILDREN: EFFECTS ON HEMATOLOGICAL FINDINGS, LIPID PROFILE AND MUSCLES. UROPEAN SOCIETY FOR PAEDIATRIC NEPHROLOGY; SO: 33RD ANNUAL MEETING OF THE EUROPEAN SOCIETY FOR PAEDIATRIC NEPHROLOGY, PRAGUE, CZECH REPUBLIC, SEPTEMBER 2-5, 1999 SPONSORED BY: EUROPEAN SOCIETY FORPAEDIATRIC NEPHROLOGY. PEDIATRIC-NEPHROLOGY, SEPT., 1999, VOL. 13, NO. 7, C82;REUNION ANNUELLE NOVEMBER 1998, LUXEMBOURGND: 27179 AU: BOUISSOU F, FABRE C, REMESY M, MESTERY D,YUNG M, CABAL G, PIQUEMAL J, MARMIN G, BOESEN G, FOURES M F, BARTHE PH. IN: NEPHROLOGIE PEDIATRIQUE, HOPITAL DES ...
    Active substance: LEVOCARNITINE
    Study summary document link (including results):
    View full study record
    Document reference: 31145
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jun 14 10:14:26 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA